Daily Stock Analysis, GSK, GlaxoSmithKline PLC, priceseries

GlaxoSmithKline PLC. Daily Stock Analysis
Stock Information
Open
40.59
Close
40.86
High
40.97
Low
40.53
Previous Close
40.37
Daily Price Gain
0.49
YTD High
41.21
YTD High Date
Feb 8, 2019
YTD Low
37.60
YTD Low Date
Jan 2, 2019
YTD Price Change
2.98
YTD Gain
7.87%
52 Week High
41.91
52 Week High Date
Nov 30, 2018
52 Week Low
34.46
52 Week Low Date
Mar 1, 2018
52 Week Price Change
5.54
52 Week Gain
15.68%
Company Information
Stock Symbol
GSK
Exchange
NYSE
Company URL
http://www.gsk.com
Company Phone
011442080475000
CEO
Emma Walmsley
Headquarters
-
Business Address
980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, UNITED KINGDOM TW8 9GS
Sector
Equity
Industry Category
Drugs
Industry Group
Drug Manufacturers - Major
CIK
0001131399
About

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare business markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.

Description

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV, as well as oncology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories under the Otrivin, Panadol, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.